BioCardia Announced A Long-term Partnership To Advance StemCardia's Investigational Pluripotent Stem Cell Product Candidate For The Treatment Of Heart Failure
BioCardia Announced A Long-term Partnership To Advance StemCardia's Investigational Pluripotent Stem Cell Product Candidate For The Treatment Of Heart Failure
BioCardia宣佈建立長期合作伙伴關係，以推進Stemcardia在研的用於治療心力衰竭的多能幹細胞候選產品
Under the partnership, BioCardia is the exclusive biotherapeutic delivery partner for StemCardia's cell therapy candidate through studies expected to result in FDA approval of an investigational new drug application (IND) and the anticipated Phase I/II clinical development to follow.
根據該合作伙伴關係，BioCardia是Stemcardia候選細胞療法的獨家生物治療交付合作夥伴，其研究預計將導致FDA批准一項在研新藥申請（IND），預計隨後將進行I/II期臨床開發。